InflaRx advances izicopan development for kidney diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to InflaRx advances izicopan development for kidney diseases
InferX Corporation (NASDAQ: IFRX) Delayed: 1.60 -0.08 (4.76%)
Previous Close $1.68    52 Week High $0.05 
Open $1.66    52 Week Low $0.00 
Day High $1.74    P/E N/A 
Day Low $1.60    EPS $0.00 
Volume 773,886